Lilly to halve planned €2.3 billion investment in Germany, CEO tells newspaper

Eli Lilly and Co

03/06/2026 16:21

BERLIN, June 3 (Reuters) - Eli Lilly LLY.N will halve its originally planned investment of €2.3 billion ($2.67 billion) in Germany, CEO Dave Ricks told the Handelsblatt business daily.
Over a billion euros has already been invested in the production site for weight-loss injections in Alzey in the western state of Rhineland-Palatinate, the German business daily reported on Wednesday.
The high-tech plant is still scheduled to begin operations in 2027, albeit at reduced capacity, the report added.

($1 = 0.8618 euros)

 (Reporting by Rachel More; Editing by Emelia Sithole-Matarise)
 ((rachel.more@thomsonreuters.com;))